ITeos Therapeutics Inc USD0.001
Sell:0.00pBuy:0.00p
No change
Prices delayed by at least 15 minutes
- This stock can be held in a
Create an alert
Stocks and Shares ISASell:0.00p
Buy:0.00p
Change:No change
No changePrices delayed by at least 15 minutes
Sell:0.00p
Buy:0.00p
Change:No change
No changePrices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 29 August 2025 | Yvonne McGrathChief Level Officer | Sell Regular sell transaction (market) | 46,300 | $10.05 | $465,176.10 | 0 |
| 29 August 2025 | David FeltquateOther Level A | Sell Regular sell transaction (market) | 47,000 | $10.05 | $472,209.00 | 0 |
| 29 August 2025 | Michel DetheuxChairman/CEO | Sell Regular sell transaction (market) | 153,903 | $10.05 | $1,546,263.44 | 0 |
| 29 August 2025 | Michel DetheuxChairman/CEO | Sell Regular sell transaction (market) | 94,027 | $10.05 | $944,689.27 | 0 |
| 29 August 2025 | Matthew (Matt) CallCOO | Sell Regular sell transaction (market) | 161,898 | $10.05 | $1,626,589.21 | 0 |
| 29 August 2025 | Ann D RhoadsDirector | Sell Regular sell transaction (market) | 27,178 | $10.05 | $273,057.37 | 0 |
| 29 August 2025 | David L. HallalChairman of the Board | Sell Regular sell transaction (market) | 25,140 | $10.05 | $252,581.58 | 0 |
| 29 August 2025 | David L. HallalChairman of the Board | Sell Regular sell transaction (market) | 146,160 | $10.05 | $1,468,469.52 | 0 |
| 29 August 2025 | Matthew (Matt) GallCFO | Sell Regular sell transaction (market) | 9,063 | $10.05 | $91,055.96 | 0 |
| 29 August 2025 | Matthew (Matt) GallCFO | Sell Regular sell transaction (market) | 89,429 | $10.05 | $898,493.16 | 0 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 15 May 2025 | ECOR1 CAPITAL LLCInvestment Fund | Buy Regular purchase transaction | 3,300,000 | $8.00 | $26,400,000.00 | 10,688,978 |
| 14 May 2025 | ECOR1 CAPITAL LLCInvestment Fund | Buy Regular purchase transaction | 1,658,978 | $7.41 | $12,285,561.58 | 7,388,978 |
| 13 May 2025 | UBS ONCOLOGY IMPACT FUND LPVenture Capital | Sell Regular sell transaction (market) | 1,031,931 | $8.06 | $8,317,363.86 | 3,452,797 |
| 13 May 2025 | MPM BIOVENTURES 2014 LPVenture Capital | Sell Regular sell transaction (market) | 630,191 | $8.06 | $5,079,339.46 | 2,108,594 |
| 29 August 2025 | Michel DetheuxChairman/CEO | Sell Regular sell transaction (market) | 444,815 | $10.05 | $4,469,056.31 | 0 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.